Blueprint MedicinesCompany Details

Get alertedif Blueprint Medicines gets funded!
United States
Detailed industries:biotechnology
Company description

Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validationâ„¢ Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat.


Funding history

Key people
Alexis BorisyCo - Founder & Board Director, Co - Founder & Board of Directors
Giulio DraettaScientific Advisor
Kyle KuvalankaChief Business Officer
Christoph LengauerChief Scientific Officer
Daniel LynchBoard Member, Executive Chairman
Deborah PalestrantStrategic Planning and Operations
Chris VarmaPresident & CEO
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!